JMCGX
Price
$31.31
Change
+$0.35 (+1.13%)
Updated
Aug 21 closing price
Net Assets
14.9M
VEXRX
Price
$126.53
Change
+$0.81 (+0.64%)
Updated
Aug 21 closing price
Net Assets
22.12B
Interact to see
Advertisement

JMCGX vs VEXRX

JMCGX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
JMCGX vs. VEXRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMCGX is a Buy and VEXRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 22.1B vs. JMCGX (14.9M). VEXRX pays higher dividends than JMCGX: VEXRX (0.49) vs JMCGX (0.45). JMCGX was incepted earlier than VEXRX: JMCGX (25 years) vs VEXRX (25 years). JMCGX (3.14) is less costly to investors than VEXRX (0.28). VEXRX is a more actively managed with annual turnover of: 51.00 vs. JMCGX (26.00). JMCGX has a lower initial minimum investment than VEXRX: JMCGX (2500) vs VEXRX (50000). VEXRX annual gain was more profitable for investors over the last year : 17.56 vs. JMCGX (16.61). VEXRX return over 5 years is better than : -5.23 vs. JMCGX (-16.15).
JMCGXVEXRXJMCGX / VEXRX
Total Expense Ratio2.300.28821%
Annual Report Gross Expense Ratio3.140.281,121%
Fund Existence25 years25 years-
Gain YTD-0.35018.596-2%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets14.9M22.1B0%
Annual Yield % from dividends0.450.4992%
Returns for 1 year16.6117.5695%
Returns for 3 years53.4334.85153%
Returns for 5 years-16.15-5.23309%
Returns for 10 years188.4255.04342%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THPMX17.600.14
+0.80%
Thompson MidCap
AIVBX22.210.17
+0.77%
American Funds Intl Vntg A
GSSUX45.930.22
+0.48%
Goldman Sachs Small Cap Value R6
TSNIX70.000.19
+0.27%
T. Rowe Price Science & Tech I
JMNAX14.04-0.01
-0.07%
JPMorgan Research Market Neutral A